Upon necropsy at an age of 36 weeks, NFAT2-deficient animals showed dramatically stronger adenopathy and splenomegaly than TCL1 transgenic mice with intact NFAT2 expression and wild-type controls (Fig. 3b and c). Here, NFATC1 is linked to lymphatic system disorder.